## **Core Concept**
Diabetic ketoacidosis (DKA) is a serious complication of diabetes characterized by hyperglycemia, metabolic acidosis, and increased ketone bodies. Management involves fluid replacement, electrolyte replenishment, and insulin therapy to suppress ketogenesis and facilitate glucose uptake.

## **Why the Correct Answer is Right**
The correct answer, **Regular insulin**, is indicated in DKA because it can be administered intravenously, allowing for precise control over blood glucose levels. Regular insulin has a rapid onset of action and a relatively short duration, making it ideal for the acute management of DKA. It works by activating insulin receptors on cells, promoting glucose uptake, and inhibiting gluconeogenesis and lipolysis, which in turn reduces ketone body production.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might seem plausible but lacks specificity regarding the type of insulin or its characteristics suitable for DKA management.
- **Option B:** This option could potentially refer to a type of insulin but is not specified; however, insulins with slower onsets or longer durations (like NPH or long-acting analogs) are not preferred in the initial management of DKA.
- **Option C:** This could imply an insulin type not typically used for acute DKA management, such as a long-acting insulin analog, which does not offer the flexibility and control needed in DKA treatment.
- **Option D:** This option might suggest another form of insulin not suitable for intravenous administration or not commonly used in DKA.

## **Clinical Pearl / High-Yield Fact**
In the management of DKA, **continuous intravenous insulin infusion** is often preferred over subcutaneous administration because it allows for more precise control over blood glucose levels. The initial insulin dose is usually a **bolus** followed by a **continuous infusion**. Monitoring blood glucose levels closely is crucial to adjust the insulin dose and prevent hypoglycemia.

## **Correct Answer:** . Regular insulin.